Search for COVID19 targets
You are searching for: Phase 2 Trial
T99685 Target Info |
Target Name | HUMAN mammalian target of rapamycin (mTOR) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS) | ||
Drugs | Sirolimus | Drug Info |
T90038 Target Info |
Target Name | HUMAN MYD88NF-kappa-B proinflammatory pathway (MYD88-NFKB pathway) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Atorvastatin | Drug Info |
T89592 Target Info |
Target Name | MERS-CoV 3C-like proteinase (3CLpro) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Middle East Respiratory Syndrome (MERS) | ||
Drugs | Lopinavir + ritonavir + interferon beta-1b | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.